ZBIO
Zenas BioPharma·NASDAQ
--
--(--)
--
--(--)
ZBIO fundamentals
Zenas BioPharma (ZBIO) released its earnings on May 15, 2025: revenue was 10.00M (YoY --), beat estimates; EPS was -0.8 (YoY --), beat estimates.
Revenue / YoY
10.00M
--
EPS / YoY
-0.8
--
Report date
May 15, 2025
Earnings Call
7:00 AM on May 15, 2025
Meeting link.EPS
Actual | -0.8 |
Forecast | -1.1336 |
Surprise | +29.43% |
Revenue
Actual | 10.00M |
Forecast | 1.67M |
Surprise | +500.00% |
Earnings Call
You can ask Aime
What is the market's earnings forecast for Zenas BioPharma next quarter?Did Zenas BioPharma beat or miss consensus estimates last quarter?What guidance did Zenas BioPharma's management provide for the next earnings period?What does Zenas BioPharma do and what are its main business segments?What were the key takeaways from Zenas BioPharma’s earnings call?What is Zenas BioPharma's latest dividend and current dividend yield?What is Zenas BioPharma's gross profit margin?What were the key takeaways from Zenas BioPharma's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
